Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.1K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K
Pedigree Analysis01:35

Pedigree Analysis

86.0K
Overview
86.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.4K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

13
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
13
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

25
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drugit: crowd-sourcing molecular design of non-peptidic VHL binders.

Nature communications·2025
Same author

Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules.

Molecular cancer therapeutics·2024
Same author

Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent <i>In Vivo</i> Activities in Mouse Models of Hematological and Solid Tumors.

Journal of medicinal chemistry·2024
Same author

Probing Protein-Ligand Methyl-π Interaction Geometries through Chemical Shift Measurements of Selectively Labeled Methyl Groups.

Journal of medicinal chemistry·2024
Same author

Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical Assays.

Journal of medicinal chemistry·2024
Same author

Ligand <sup>1</sup> H NMR Chemical Shifts as Accurate Reporters for Protein-Ligand Binding Interfaces in Solution.

Chemphyschem : a European journal of chemical physics and physical chemistry·2023

Related Experiment Video

Updated: Oct 13, 2025

In Vitro Biochemical Assays using Biotin Labels to Study Protein-Nucleic Acid Interactions
08:14

In Vitro Biochemical Assays using Biotin Labels to Study Protein-Nucleic Acid Interactions

Published on: July 17, 2019

12.9K

Biotin's Lessons in Drug Design.

Darryl B McConnell1

  • 1Discovery Research, Boehringer Ingelheim Regional Center Vienna GmbH & Co KG, 1120 Vienna, Austria.

Journal of Medicinal Chemistry
|November 16, 2021
PubMed
Summary

Biotin achieves exceptionally strong protein binding using nonclassical hydrogen bonds and its flexible side chain. These unique binding strategies offer valuable lessons for improving drug design and discovering high-affinity molecules.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Structural Biology

Background:

  • High-affinity ligand-protein interactions are crucial for effective drug design.
  • Biotin exhibits remarkable binding affinity to avidin and streptavidin, reaching femtomolar and picomolar levels, respectively.
  • Biotin's binding efficiency is notable given its small molecular weight (240 Da).

Purpose of the Study:

  • To elucidate the molecular mechanisms behind biotin's exceptionally strong noncovalent binding.
  • To identify non-standard binding strategies employed by biotin for potential application in drug design.
  • To highlight the importance of nonclassical hydrogen bonds in protein-ligand interactions.

Main Methods:

  • Analysis of biotin's binding interactions with avidin and streptavidin.

More Related Videos

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration
12:03

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration

Published on: January 22, 2014

33.8K
Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials
10:28

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

9.1K

Related Experiment Videos

Last Updated: Oct 13, 2025

In Vitro Biochemical Assays using Biotin Labels to Study Protein-Nucleic Acid Interactions
08:14

In Vitro Biochemical Assays using Biotin Labels to Study Protein-Nucleic Acid Interactions

Published on: July 17, 2019

12.9K
Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration
12:03

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration

Published on: January 22, 2014

33.8K
Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials
10:28

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

9.1K
  • Examination of the role of biotin's flexible valeric acid side chain.
  • Investigation of nonclassical hydrogen bonds (CH-π, CH-O) and classical hydrogen bonds.
  • Assessment of the contribution of the oxyanion hole, sulfur-centered H-bonds, and water solvation.

    • Main Results:

    • Biotin's high affinity is primarily driven by its flexible valeric acid side chain interacting with the protein's lipophilic binding pocket.
    • Nonclassical hydrogen bonds (CH-π, CH-O) play a significant role in biotin's binding.
    • Additional contributions to binding include an oxyanion hole, sulfur-centered H-bonds, and ordered water molecules in the complex.

    Conclusions:

    • Biotin's binding strategies, particularly its use of nonclassical hydrogen bonds and side-chain interactions, offer a powerful model for drug design.
    • Medicinal chemistry should consider adopting these non-standard binding approaches to enhance ligand-protein affinity.
    • Understanding and applying biotin's binding principles can lead to the development of more potent and effective therapeutic agents.